Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing United Kingdom Population (ACEL-UK): Cohort Study - Top-Institutions - MDSpire

Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing United Kingdom Population (ACEL-UK): Cohort Study

  • By

  • Mia Holley

  • Salman Razvi

  • Ian Maxwell

  • Rosie Dew

  • Scott Wilkes

  • April 3, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    University of Oxford
    University of Oxford

    Oxford, Oxfordshire

    Key Differentiators

    • Endocrinology
    • Epidemiology
    • Geriatrics

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Cardiology
    • Geriatrics

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Endocrinology
    • Cardiology
    • Epidemiology

  • #4

    Imperial College London
    Imperial College London

    London, Greater London

    Key Differentiators

    • Endocrinology
    • Public Health
    • Geriatrics

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm County

    Key Differentiators

    • Endocrinology
    • Epidemiology
    • Geriatrics

Original Source(s)

Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing United Kingdom Population (ACEL-UK): Cohort Study

  • by Mia Holley, Salman Razvi, Ian Maxwell, Rosie Dew, Scott Wilkes

  • April 3, 2025

Related Content

Predicting poor response to anti-osteoporosis therapy: a machine learning model integrating clinical and novel biomarker data

Case Report: Tibial plateau fracture in Charcot neuroarthropathy: a report of two cases with contrasting outcomes

Comparative efficacy and safety of odanacatib, abaloparatide, denosumab, teriparatide, and bisphosphonates for male osteoporosis: a systematic review and network meta-analysis